Login / Signup

Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?

Mehmet Zahid KoçakMuhiddin ErMuzaffer UgrakliEngin HendemMurat ArazMelek Karakurt EryilmazMehmet Artac
Published in: European journal of clinical pharmacology (2023)
This study demonstrated that concomitant usage of beta blockers improved both survival outcomes, irrespective of the kind of beta blocker.
Keyphrases
  • angiotensin converting enzyme
  • squamous cell carcinoma
  • small cell lung cancer
  • angiotensin ii